Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,83%
1 082,40
-9,11
-0,83%
1 091,511 090,401 090,401 080,18
SIXC
Communications
SIXC
Communications
SIXC
-0,41%
607,61
-2,50
-0,41%
610,11610,11610,29606,17
SIXE
Energy
SIXE
Energy
SIXE
+1,14%
1 252,11
+14,13
+1,14%
1 237,981 237,831 250,661 225,03
SIXI
Industrials
SIXI
Industrials
SIXI
-0,92%
1 728,62
-16,09
-0,92%
1 744,711 740,951 747,291 728,91
SIXM
Financials
SIXM
Financials
SIXM
-0,35%
637,94
-2,24
-0,35%
640,18639,92643,19636,70
SIXR
Staples
SIXR
Staples
SIXR
-0,02%
849,44
-0,14
-0,02%
849,58845,27851,68841,28
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,08%
217,66
+0,18
+0,08%
217,48217,48218,16216,39
SIXT
Technology
SIXT
Technology
SIXT
-0,28%
3 251,61
-9,08
-0,28%
3 260,693 273,363 287,813 250,72
SIXU
Utilities
SIXU
Utilities
SIXU
+0,36%
945,86
+3,41
+0,36%
942,45939,39948,80934,04
SIXV
Health care
SIXV
Health care
SIXV
-0,15%
1 464,58
-2,22
-0,15%
1 466,801 464,701 467,191 458,68
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,73%
2 379,98
-17,52
-0,73%
2 397,502 395,032 412,012 382,77
SHPHF:OTCMKTS
Sihuan Pharmaceutical Holdings Group Ltd
USD 0,19
0,00%
(0,00) 1D
6 Mrt., 14:30:53 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHPHF...
Mkt. cap
11,52 mjd
Volume
0,00
52-wk high
USD 0,21
52-wk low
USD 0,10
Beta
0,58
Shares outstanding
9,33 mjd
No. of employees
3 k
News stories
From sources across the web
Profile
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market. Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
About Sihuan Pharmaceutical Holdings Group Ltd
CEOGuo Weicheng
Employees2,84 k
Founded2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
573,10 m
573,10 m
735,90 m
735,90 m
Cost of goods sold
194,47 m
194,47 m
213,60 m
213,60 m
Cost of revenue
194,47 m
194,47 m
213,60 m
213,60 m
Research and development expenses
76,42 m
76,42 m
69,21 m
69,21 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
221,66 m
221,66 m
337,39 m
337,39 m
Operating expense
275,58 m
275,58 m
386,99 m
386,99 m
Total operating expenses
470,05 m
470,05 m
600,59 m
600,59 m
Operating income
103,05 m
103,05 m
135,31 m
135,31 m
Other non operating income
-
-
-
-
EBT including unusual items
78,46 m
78,46 m
130,12 m
130,12 m
EBT excluding unusual items
72,60 m
72,60 m
111,67 m
111,67 m
Income tax expense
45,36 m
45,36 m
70,51 m
70,51 m
Effective tax rate
57,82%
57,82%
54,19%
54,19%
Other operating expenses
-22,51 m
-22,51 m
-19,61 m
-19,61 m
Net income
51,30 m
51,30 m
38,55 m
38,55 m
Net profit margin
8,95%
8,95%
5,24%
5,24%
Earnings per share
-
-
-
-
Interest and investment income
24,80 m
24,80 m
24,62 m
24,62 m
Interest expense
-52,48 m
-52,48 m
-48,30 m
-48,30 m
Net interest expenses
-27,69 m
-27,69 m
-23,69 m
-23,69 m
Depreciation and amortization charges
-
-
-
-
EBITDA
152,06 m
152,06 m
184,32 m
185,33 m
Gain or loss from assets sale
-5,87 m
-5,87 m
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more